AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 120 filers reported holding AURINIA PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.28 and the average weighting 0.3%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,489,891 | -23.0% | 963,950 | -4.1% | 0.01% | -16.7% |
| Q2 2023 | $9,725,554 | +4.6% | 1,004,706 | +18.4% | 0.01% | -14.3% |
| Q1 2023 | $9,301,040 | +153.4% | 848,635 | -0.1% | 0.01% | +133.3% |
| Q4 2022 | $3,670,717 | -42.6% | 849,703 | -0.1% | 0.00% | -40.0% |
| Q3 2022 | $6,397,000 | -26.1% | 850,680 | -1.3% | 0.01% | -16.7% |
| Q2 2022 | $8,660,000 | -8.7% | 861,737 | +12.4% | 0.01% | 0.0% |
| Q1 2022 | $9,488,000 | -46.0% | 766,414 | -0.2% | 0.01% | -33.3% |
| Q4 2021 | $17,569,000 | +7885.9% | 768,195 | +7641.6% | 0.01% | – |
| Q3 2021 | $220,000 | +18.3% | 9,923 | -30.9% | 0.00% | – |
| Q2 2021 | $186,000 | +481.2% | 14,370 | +490.1% | 0.00% | – |
| Q1 2021 | $32,000 | -39.6% | 2,435 | -36.1% | 0.00% | – |
| Q4 2020 | $53,000 | -65.6% | 3,809 | -63.7% | 0.00% | – |
| Q3 2020 | $154,000 | -53.0% | 10,492 | -48.2% | 0.00% | – |
| Q2 2020 | $328,000 | +245.3% | 20,255 | +207.5% | 0.00% | – |
| Q1 2020 | $95,000 | -63.0% | 6,586 | -48.0% | 0.00% | – |
| Q4 2019 | $257,000 | +1017.4% | 12,666 | +200.2% | 0.00% | – |
| Q3 2019 | $23,000 | +64.3% | 4,219 | +97.8% | 0.00% | – |
| Q2 2019 | $14,000 | +75.0% | 2,133 | +70.1% | 0.00% | – |
| Q1 2019 | $8,000 | – | 1,254 | +2180.0% | 0.00% | – |
| Q4 2018 | $0 | – | 55 | +5.8% | 0.00% | – |
| Q3 2018 | $0 | -100.0% | 52 | -98.3% | 0.00% | – |
| Q2 2018 | $17,000 | -5.6% | 3,000 | -10.9% | 0.00% | – |
| Q1 2018 | $18,000 | -21.7% | 3,366 | -30.4% | 0.00% | – |
| Q4 2017 | $23,000 | +21.1% | 4,835 | +61.2% | 0.00% | – |
| Q3 2017 | $19,000 | +5.6% | 3,000 | 0.0% | 0.00% | – |
| Q2 2017 | $18,000 | -86.4% | 3,000 | -83.3% | 0.00% | – |
| Q1 2017 | $132,000 | – | 18,000 | +299900.0% | 0.00% | – |
| Q4 2015 | $0 | – | 6 | -85.0% | 0.00% | – |
| Q1 2015 | $0 | -100.0% | 40 | -76.6% | 0.00% | – |
| Q4 2014 | $1,000 | – | 171 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 503,248 | $6,535,000 | 10.30% |
| Prosight Management, LP | 360,834 | $4,685,000 | 3.84% |
| Healthcare Value Capital, LLC | 100,000 | $1,299,000 | 2.89% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,748,208 | $22,700,000 | 2.32% |
| DG Capital Management, LLC | 591,154 | $7,676,000 | 1.83% |
| NEA Management Company, LLC | 5,172,683 | $67,193,000 | 1.51% |
| Altium Capital Management LP | 408,908 | $5,310,000 | 1.47% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 170,316 | $2,212,000 | 1.17% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 298,500 | $3,875,000 | 1.02% |
| KNOTT DAVID M | 154,840 | $2,011,000 | 0.86% |